GRAL
GRAIL Inc.
$68.96
+$1.77(+2.63%)
66
Overall
60
Value
83
Tech
55
Quality
Market Cap
$2.97B
Volume
935.12K
52W Range
$29.95 - $118.84
Target Price
$66.86
Company Overview
| Mkt Cap | $2.97B | Price | $68.96 |
| Volume | 935.12K | Change | +2.63% |
| P/E Ratio | -7.3 | Open | $67.34 |
| Revenue | $147.2M | Prev Close | $67.19 |
| Net Income | $-408.4M | 52W Range | $29.95 - $118.84 |
| Div Yield | N/A | Target | $66.86 |
| Overall | 66 | Value | 60 |
| Quality | 55 | Technical | 83 |
No chart data available
About GRAIL Inc.
GRAIL, Inc., a commercial-stage healthcare company, focuses on developing technologies for early cancer detection in the United States and internationally. It provides Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company offers development services including support for ongoing clinical studies, pilot testing, research, and therapy development. It also develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Latest News
Grail Inc. Earnings Call Highlights Growth Amid Risks
TipRanks Auto-Generated Newsdesk•16 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRAL | $68.96 | +2.6% | 935.12K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |